China Health Industries Holdings, Inc. (CHHE) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cotizando a $, China Health Industries Holdings, Inc. (CHHE) es una empresa del sector Healthcare valorada en 0. La acción obtiene una puntuación de 59/100, una calificación moderada basada en 9 KPI cuantitativos.
Ultimo analisis: 16 mar 2026China Health Industries Holdings, Inc. (CHHE) Resumen de Asistencia Médica y Tuberías
China Health Industries Holdings, Inc. is a manufacturer and seller of health products, including hemp-derived items and health supplements, operating primarily in China. The company's diverse product line targets various health needs, sold through a network of sales agents, positioning it within the specialty and generic drug manufacturing sector.
Tesis de Inversión
China Health Industries Holdings, Inc. operates in the growing Chinese health and wellness market. The company's diverse product line, including hemp-derived products and health supplements, caters to a wide range of consumer needs. However, the company's negative profit margin of -366.6% and lack of dividend payments raise concerns about its financial stability. The company's high beta of -20.54 suggests high volatility. Growth catalysts include expanding its sales agent network and introducing new products. The company's success depends on improving profitability and managing its operational costs effectively.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- China Health Industries Holdings, Inc. operates with a market capitalization of $0.00B, indicating a micro-cap status.
- The company's P/E ratio is -0.02, reflecting negative earnings.
- The profit margin is -366.6%, indicating significant losses.
- Gross margin is 0.2%, suggesting minimal profitability from sales.
- The company's beta is -20.54, indicating high volatility relative to the market.
Competidores y Pares
Fortalezas
- Diverse product portfolio including hemp derivatives and health supplements.
- Established sales agent network in China.
- Proprietary formulations for certain products.
- Focus on specific health needs such as skin care and bone density.
Debilidades
- Negative profit margin indicating financial instability.
- High beta suggesting high volatility.
- Dependence on sales agents for distribution.
- Limited geographic reach primarily focused on China.
Catalizadores
- Upcoming: Potential expansion of sales agent network in new regions within China.
- Upcoming: Launch of new hemp-derived products targeting specific health needs.
- Ongoing: Increasing demand for health supplements in the Chinese market.
- Ongoing: Growing awareness of the benefits of hemp-derived products.
- Upcoming: Potential partnerships with e-commerce platforms to expand online sales.
Riesgos
- Potential: Negative profit margin may continue, impacting financial stability.
- Ongoing: Intense competition from other health product manufacturers.
- Potential: Changing regulations regarding hemp-derived products.
- Ongoing: Dependence on sales agents for distribution.
- Potential: Economic downturn affecting consumer spending on health products.
Oportunidades de crecimiento
- Expanding the Sales Agent Network: China Health Industries Holdings can grow by expanding its network of sales agents across China. The market for health products in China is vast, with increasing demand in both urban and rural areas. By increasing its sales agent network, the company can reach a wider customer base and increase sales volume. This expansion can be achieved within the next 1-2 years, potentially increasing revenue by 15-20%.
- Introducing New Hemp-Derived Products: The market for hemp-derived products is growing rapidly, driven by increasing awareness of their health benefits. China Health Industries Holdings can capitalize on this trend by introducing new hemp-derived products, such as CBD-infused supplements and skincare items. The global CBD market is projected to reach $20 billion by 2025, offering a significant opportunity for the company. Launching these products within the next year could boost revenue by 10-15%.
- Developing New Health Supplements: The demand for health supplements is increasing as consumers become more health-conscious. China Health Industries Holdings can develop new health supplements targeting specific health needs, such as weight management, immune support, and cognitive enhancement. The global health supplement market is expected to reach $230 billion by 2027, providing a substantial growth opportunity. Introducing these supplements within the next 18 months could increase revenue by 12-18%.
- Entering E-commerce Platforms: The e-commerce market in China is booming, providing a convenient channel for consumers to purchase health products. China Health Industries Holdings can partner with major e-commerce platforms like Alibaba and JD.com to sell its products online. E-commerce sales in China are projected to reach $3 trillion by 2024, offering a significant opportunity for the company to expand its reach. Establishing an online presence within the next 6-12 months could increase revenue by 8-12%.
- Strategic Partnerships with Healthcare Providers: Collaborating with hospitals, clinics, and wellness centers can provide China Health Industries Holdings with access to a broader customer base and enhance its brand credibility. These partnerships can involve joint marketing initiatives, product recommendations by healthcare professionals, and distribution agreements. The healthcare market in China is rapidly expanding, driven by government initiatives to improve healthcare access and quality. Forming these partnerships within the next year could lead to a 10-15% increase in revenue.
Oportunidades
- Expanding the sales agent network to reach more customers.
- Introducing new hemp-derived products to capitalize on market trends.
- Developing new health supplements targeting specific health needs.
- Entering e-commerce platforms to expand online sales.
Amenazas
- Intense competition from other health product manufacturers.
- Changing regulations regarding hemp-derived products.
- Economic downturn affecting consumer spending on health products.
- Potential supply chain disruptions.
Ventajas competitivas
- Established presence in the Chinese health product market.
- Diverse product portfolio catering to various health needs.
- Proprietary formulations for health supplements.
- Distribution network through sales agents.
Acerca de CHHE
China Health Industries Holdings, Inc. is a health product manufacturer and seller based in Harbin City, People's Republic of China. The company operates through its subsidiaries, focusing on developing, manufacturing, and distributing a range of health-related products. These include hemp derivative products like hemp oil, hemp protein powder, hemp polypeptides, collagen peptides, hemp essence repair lotions, hemp revitalizing essence products, hemp anti-aging brightening eye creams, and hemp frozen age nourishing creams. Additionally, they offer health supplements under the QunLe and Kindlink brands, addressing various health concerns such as freckle removal, skin moisture, and overall wellness. The company's product portfolio extends to medical drugs and supplements targeting acne removal, eyestrain relief, bone density enhancement, memory improvement, and anemia. China Health Industries Holdings sells its products primarily through sales agents, focusing on the Chinese market. With a small team of 32 employees, the company aims to cater to the growing demand for health and wellness products in China.
Qué hacen
- Manufactures and sells hemp derivative products, including hemp oil and protein powder.
- Offers health supplements under the QunLe and Kindlink brands.
- Provides products for freckle removal, skin moisture, and overall wellness.
- Sells medical drugs for various health conditions.
- Offers supplements for acne removal, eyestrain relief, and bone density enhancement.
- Provides iron, multivitamin, and mineral supplements.
- Sells products through sales agents in China.
Modelo de Negocio
- Develops and manufactures health products, including hemp derivatives and supplements.
- Sells products through a network of sales agents.
- Focuses on the Chinese market.
- Generates revenue through product sales.
Contexto de la Industria
China Health Industries Holdings, Inc. operates within the specialty and generic drug manufacturing industry, a segment experiencing growth due to increasing healthcare awareness and demand for affordable medicines. The Chinese market is characterized by intense competition, with numerous domestic and international players. Key trends include a focus on preventive healthcare, personalized medicine, and the integration of traditional Chinese medicine with modern pharmaceuticals. China Health Industries Holdings competes with companies like BQST, ECGS, LUFFF, MCUJF, and MYCOF, all vying for market share in this dynamic landscape.
Clientes Clave
- Consumers seeking health and wellness products.
- Individuals looking for supplements for specific health needs.
- Customers in the Chinese market.
- Patients requiring medical drugs.
Finanzas
Gráfico e información
Precio de la acción de China Health Industries Holdings, Inc. (CHHE): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para CHHE.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para CHHE.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para CHHE.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de CHHE en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: Sun Xin
CEO
Sun Xin is the CEO of China Health Industries Holdings, Inc. He oversees the company's operations, strategic direction, and overall performance. His background includes experience in managing teams and driving business growth within the health product industry. He is responsible for leading the company's efforts in manufacturing and selling health products, including hemp derivatives and health supplements, in the Chinese market.
Historial: Under Sun Xin's leadership, China Health Industries Holdings has focused on expanding its product portfolio and strengthening its sales agent network. Key milestones include the introduction of new hemp-derived products and the development of health supplements targeting specific health needs. He manages a team of 32 employees.
Información del mercado OTC de CHHE
The OTC Other tier represents the lowest tier of the OTC market, indicating that China Health Industries Holdings, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting and may not be subject to the same level of regulatory scrutiny as those listed on major exchanges like the NYSE or NASDAQ. This tier often includes companies with higher risk profiles and less liquidity.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure increases the risk of investing due to lack of transparency.
- Low trading volume and wide bid-ask spread can make it difficult to buy or sell shares.
- Potential for delisting or suspension from the OTC market due to non-compliance.
- Higher risk of fraud or manipulation compared to companies listed on major exchanges.
- Limited regulatory oversight increases the risk of investing in OTC Other stocks.
- Verify the company's financial statements and SEC filings (if any).
- Check the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's compliance with regulatory requirements.
- Review the company's history of stock promotions and investor relations activities.
- Consult with a financial advisor or legal professional before investing.
- Confirm the company's contact information and physical address.
- Company manufactures and sells health products.
- Company has a physical presence in Harbin City, China.
- Company has been in operation for several years.
- Company has a team of 32 employees.
Preguntas Comunes Sobre CHHE
¿Cuáles son los factores clave para evaluar CHHE?
China Health Industries Holdings, Inc. (CHHE) actualmente tiene una puntuación IA de 59/100, indicando puntuación moderada. Fortaleza clave: Diverse product portfolio including hemp derivatives and health supplements.. Riesgo principal a monitorear: Potential: Negative profit margin may continue, impacting financial stability.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de CHHE?
CHHE actualmente puntúa 59/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de CHHE?
Los precios de CHHE se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre CHHE?
La cobertura de analistas para CHHE incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en CHHE?
Las categorías de riesgo para CHHE incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Negative profit margin may continue, impacting financial stability.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de CHHE?
La relación P/E para CHHE compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está CHHE sobrevalorada o infravalorada?
Determinar si China Health Industries Holdings, Inc. (CHHE) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de CHHE?
China Health Industries Holdings, Inc. (CHHE) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Limited information available due to OTC Other listing and lack of analyst coverage.
- Financial data based on the most recent available information.
- AI analysis pending for CHHE.